103 results
Page 3 of 6
8-K
EX-99.1
dk41khj6k7a7kmfc
9 Aug 22
Revolution Medicines Reports Second Quarter 2022 Financial Results and Update on Corporate Progress
12:00am
424B5
ajir6qmdmqr1z 2n
20 Jul 22
Prospectus supplement for primary offering
4:02pm
424B5
xxf2wa 6v4iqd9n0f7sd
19 Jul 22
Prospectus supplement for primary offering
4:01pm
8-K
EX-99.1
clsuh2hg937
9 May 22
Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress
4:07pm
8-K
EX-99.1
c3f1yrqz145kcj nqy
28 Feb 22
Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress
4:06pm
8-K
u93fdkf0pumgrh8
11 Jan 22
Results of Operations and Financial Condition
2:16pm
424B5
tqe331ecjtxl0os
10 Nov 21
Prospectus supplement for primary offering
4:31pm
8-K
EX-99.1
ej1lg4je
10 Nov 21
Revolution Medicines Reports Third Quarter Financial Results and Update on Corporate Progress
4:06pm
8-K
ilkpvstf306zgat piwn
4 Nov 21
Entry into a Material Definitive Agreement
4:17pm
8-K
EX-99.1
6epc2tk
11 Aug 21
Revolution Medicines Reports Second Quarter Financial Results and Update on Corporate Progress
4:06pm
8-K
EX-99.1
6lm9sxm0yqpw j9
10 May 21
Revolution Medicines Reports First Quarter Financial Results and Update on Corporate Progress
4:05pm